The patient and provider interviews identified a total of 83 ADRs, compared with 1 ADR identified by the passive reporting system. When providers were made aware of the ADRs they had not ...

Bernstein analyst Eunice Lee maintained a Hold rating on XPeng, Inc. ADR (XPEV – Research Report) yesterday and set a price target of $14.00.

Background: Spontaneous adverse drug reaction (ADR) reporting is the cornerstone of pharmacovigilance. ADR reporting with Yellow Cards has tremendously improved pharmacovigilance of drugs in many ...

Only one-third of electoral trusts reported donations in FY 2023-24, with BJP receiving 70.3% of ₹1,218.39 crore, raising ...

This was the ADR's sixth consecutive day of gains.

In a report released today, Ming-Hsun Lee from Bank of America Securities maintained a Buy rating on XPeng, Inc. ADR (XPEV – Research Report), ...

Veritext, the court-reporting business that is steadily ‘rolling-up’ a mass of smaller groups in the US, is now pushing ...